1-Amino-4-(4-chlorophenyl)aminoanthraquinone-2-sulfonicacidsodiumsalt
|
- $182 - $1127
- Product name: 1-Amino-4-(4-chlorophenyl)aminoanthraquinone-2-sulfonicacidsodiumsalt
- CAS: 78510-31-3
- MF: C20H12ClN2NaO5S
- MW: 450.82745
- EINECS:
- MDL Number:MFCD09971094
- Synonyms:1-Amino-4-(4-chlorophenyl)aminoanthraquinone-2-sulfonicacidsodiumsalt;PSB 069;PSB069,PSB-069
5 prices
Selected condition：
Brand
- ApexBio Technology
- Tocris
- Usbiological
Package
- 50
- 10mg
- 10
- 50mg
- ManufacturerApexBio Technology
- Product numberB7112
- Product descriptionPSB069
- Packaging10mg
- Price$266
- Updated2021-12-16
- Buy
- ManufacturerApexBio Technology
- Product numberB7112
- Product descriptionPSB069
- Packaging50mg
- Price$1127
- Updated2021-12-16
- Buy
- ManufacturerTocris
- Product number2573
- Product descriptionPSB069 ≥98%(HPLC)
- Packaging10
- Price$182
- Updated2021-12-16
- Buy
- ManufacturerTocris
- Product number2573
- Product descriptionPSB069 ≥98%(HPLC)
- Packaging50
- Price$767
- Updated2021-12-16
- Buy
- ManufacturerUsbiological
- Product number256347
- Product descriptionPSB 069
- Packaging10mg
- Price$423
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| ApexBio Technology | B7112 | PSB069 | 10mg | $266 | 2021-12-16 | Buy |
| ApexBio Technology | B7112 | PSB069 | 50mg | $1127 | 2021-12-16 | Buy |
| Tocris | 2573 | PSB069 ≥98%(HPLC) | 10 | $182 | 2021-12-16 | Buy |
| Tocris | 2573 | PSB069 ≥98%(HPLC) | 50 | $767 | 2021-12-16 | Buy |
| Usbiological | 256347 | PSB 069 | 10mg | $423 | 2021-12-16 | Buy |
Properties
Melting point :>300 °C
storage temp. :Store at RT
solubility :Soluble to 100 mM in DMSO and to 50 mM in ethanol
form :Powder
color :Pale purple to purple
storage temp. :Store at RT
solubility :Soluble to 100 mM in DMSO and to 50 mM in ethanol
form :Powder
color :Pale purple to purple
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|